Novel apocarotenoid metabolites derived from lycopene and beta-carotene are being developed as treatments to improve maize growth and yield under salt and drought stress. Building on validated rice results, the research targets optimized concentrations of beta-cyclocitral, anchorene, and retinal to strengthen root architecture and stress resilience in maize.
Maize is the most important crop in America, yet it has limited tolerance to drought and salt stress, both of which are intensifying with climate change. This research program is developing novel apocarotenoid metabolites as treatments to enhance maize vigor and yield in farmland that requires heavy irrigation. The work builds on the lab's prior discovery of three root regulatory compounds (beta-cyclocitral, anchorene, and retinal) that have demonstrated the ability to promote plant growth and resilience during stress in rice. The current focus is translating these findings to maize and validating their performance under salt and drought conditions.
The program is at an early-to-mid stage of development. Optimal concentrations of beta-cyclocitral have been identified in maize under non-stress conditions, and work is now focused on testing performance under salt and drought stress. The underlying biology has been validated in rice, and the team is currently translating and optimizing the approach for maize using neural network-guided concentration prediction. Further validation in field-relevant conditions is planned.
UC San Diego is a comprehensive public research university in La Jolla, anchored by an integrated academic health system. On the east campus, the 23‑acre Science Research Park co‑locates corporate R&D with university programs and connects to the health sciences district, enabling daily interaction among scientists, clinicians, and companies. The Jacobs School’s Corporate Affiliates Program provides structured engagement and recruiting, while the Office of Innovation & Commercialization supports IP, licensing, and startup formation. The research enterprise is sustained by competitive federal funding, with recent awards exceeding $1.7B annually. Established commercialization pathways streamline sponsored research and help partners move from proof of concept to deployment.